Safety and Efficacy of Motor Cortex Stimulation in the Treatment of Advanced Parkinson Disease

NCT00159172 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2007-03-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether motor cortex stimulation, a mildly invasive surgical procedure, is safe and effective in advanced stage Parkinsonian patients who display side effects with dopaminergic treatment.

Conditions

  • Parkinson Disease

Interventions

DEVICE

Motor cortex stimulation

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Stephane Palfi, MD, PhD · Paris 12 University- APHP

Study Design

Allocation
RANDOMIZED
Purpose
ECT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2008-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00159172 on ClinicalTrials.gov